Yahoo Finance

Isomorphic Labs Raises $2.1 Billion to End Disease With AI

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Your Story

Isomorphic Labs Raises $2.1 Billion To Scale AI Drug Discovery

The race to use artificial intelligence for designing medicines is rapidly becoming one of the most expensive and closely watched bets in technology and biotech. On 12 May 2026, Isomorphic Labs ...
CIOL

Backed By Alphabet, Isomorphic Labs Raises $2.1 Billion To Scale AI Drug Discovery Platform

Isomorphic Labs, the AI-first drug discovery company founded by Demis Hassabis, has raised $2.1 billion in a Series B funding round as competition intensifies around artificial intelligence-driven ...
Forbes

Isomorphic Labs’ $2.1 Billion Fundraise Is The Biggest Bet Yet On AI Drug Discovery

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Demis Hassabis, CEO of Isomorphic and Google DeepMind Isomorphic, which formed as an ...
Reuters

Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery

May 12 (Reuters) - Isomorphic Labs, an artificial intelligence-driven drug discovery company, said on Wednesday it has raised $2.1 billion in its latest funding round led by existing investor Thrive ...
Bloomberg L.P.

DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI

Alphabet Inc.’s Isomorphic Labs raised $2.1 billion in its second round of outside capital, with new support from sovereign wealth funds, as it seeks to make artificial intelligence-designed drugs a ...
FierceBiotech

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

If any proof was needed that big money is still available for AI drug development, look no further than the ten-figure series B hauled in by Isomorphic Labs. The London-based AI drug discovery firm ...
Seeking Alpha

Google’s Isomorphic Labs reportedly eyeing more than $2B in new funding round

Advanced discussions are underway to raise more than $2B for Isomorphic Labs, an AI-driven drug discovery firm spun out of Alphabet's (GOOG) Google DeepMind, as part of a new funding round, Bloomberg ...
SiliconANGLE

Alphabet’s Isomorphic Labs reportedly raising $2B+ for its medical research AI

Isomorphic Labs Inc., an Alphabet Inc. unit using artificial intelligence to speed up drug development, is reportedly in talks to raise a new funding round. Sources told Bloomberg today that the ...
The News International

AI drug breakthrough: Google DeepMind spinoff Isomorphic Labs begins human trials

Isomorphic Labs, the UK-based biotech spinoff of Google DeepMind, is set to begin human trials of drugs designed by its Nobel Prize-winning AI technology. No one can deny the role of Google DeepMind ...
Wired

AI-Designed Drugs by a DeepMind Spinoff Are Headed to Human Trials

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting pipeline of new medicines.” Isomorphic Labs, the UK-based biotech spinoff of ...